Recombined staphylococcus aureus enterotoxin M oral preparation and application thereof

A technology of Staphylococcus aureus enterotoxin and staphylococcus entero, applied in the field of bioengineering, can solve the problems of simplicity, instability between batches, and easy introduction of other protein impurities.

Inactive Publication Date: 2008-10-29
ZHEJIANG UNIV
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above-mentioned method for extracting enterotoxin from the fermentation metabolites of Staphylococcus aureus has certain deficiencies, such as simple preparation process, lack of strict quality control standards, instability between batches, and easy introduction of other protein impurities, etc., thereby affecting the purity of the final product , activity and quality

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombined staphylococcus aureus enterotoxin M oral preparation and application thereof
  • Recombined staphylococcus aureus enterotoxin M oral preparation and application thereof
  • Recombined staphylococcus aureus enterotoxin M oral preparation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Example 1: PCR amplification of the gene sequence encoding the mature peptide of the SEM protein containing restriction sites:

[0047] Design the following primer sequences:

[0048] SEQ ID NO. 3: ca g gat cc t ttt gct att cgc aaa atc ​​ata tcg ca (the underlined part is the BamHI restriction site)

[0049] SEQ ID NO.4: gc c tcg ag t caa ctt tcg tcc tta taa gat att tct ac (the underlined part is the XhoI restriction site)

[0050] Using the genome of Staphylococcus aureus (FRI 1230) as a template, it is used to amplify the mature peptide gene fragment sem of Staphylococcus aureus enterotoxin SEM;

[0051] The conditions for PCR amplification were as follows. The gene fragments encoding SEM mature peptides were amplified, wherein each gene fragment had a BamH I restriction site at the 5' end and an Xho I restriction site after the terminator at the 3' end.

[0052] PCR system:

[0053] h 2 O: 60 μL

[0054] Buffer(10×): 10μL

[0055] Mg 2+ (25mmol / L): 8μL

[...

Embodiment 2

[0068] Example 2: Construction of the recombinant plasmid pGEM-T-SEM encoding enterotoxin SEM protein mature peptide gene sem containing restriction sites:

[0069]The gene fragment encoding the mature peptide of SEM protein with restriction sites obtained by PCR amplification was cloned into the pGEM-T plasmid to construct the pGEM-T-SEM recombinant plasmid, which was transformed into Escherichia coli DH5α for amplification. The above recombinant pGEM-T-SEM plasmid was extracted, identified by enzyme digestion, and then sent for sequencing. The sequencing results showed that the gene sequence encoding the mature peptide of the SEM protein with the enzyme digestion site obtained above was different from the corresponding gene sequence on GenBank except at the 5' The rest of the site is exactly the same except for the addition of a restriction site, and the amino acid sequence of the corresponding enterotoxin M mature peptide has only two more amino acids (Gly-Ser) at the N-term...

Embodiment 3

[0070] Example 3: Construction of pGEX-4T-1-SEM recombinant expression plasmid containing the gene encoding SEM mature peptide with restriction site:

[0071] The pGEM-T-SEM recombinant plasmid and the pGEX-4T-1 plasmid obtained in Example 2 containing the gene fragment encoding the mature peptide of the SEM protein obtained in Example 2 were respectively digested with BamH I and Xho I. The gene fragment encoding the mature peptide of SEM containing the restriction site and the large fragment of the pGEX-4T-1 plasmid digestion product after digestion were respectively recovered and ligated to construct the expression plasmid pGEX-4T-1-SEM. The above-mentioned recombinant expression plasmid was transformed into Escherichia coli DH5α to amplify and extract the plasmid. After digestion and identification by BamH I and Xho I, the results showed that the target gene fragment had been inserted into the vector plasmid. The electrophoresis results are shown in Figure 3 of the specifica...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a recombinant staphylococcal enterotoxin M oral preparation, the recombinant staphylococcal enterotoxin M has SEQ ID NO.1 amino acid sequence, and the oral preparation further comprises a pharmaceutical allowable drug excipient or a carrier. The oral preparation proves that the protein can enter the systemic blood circulation by penetrating epithelial cells on small intestine with the form of complete molecules and maintain the super-antigen activity for promoting the spleen lymphocyte proliferation and inhibiting the growth of tumor cells, as well as the application in the preparation of drugs for treating malignant tumors and other serious complications by the Caco-2 monolayer cell transmembrane transport test.

Description

technical field [0001] The invention belongs to bioengineering, and relates to the preparation of recombinant staphylococcal enterotoxin M (Staphylococcal Enterotoxin M, SEM), the preparation of oral preparation with SEM as the main active ingredient and its application in tumor treatment. Specifically, it is to use genetic engineering to prepare high-purity recombinant Staphylococcus aureus enterotoxin M protein and related protein products, and prepare them into oral preparations for the treatment and rehabilitation of tumor patients. Background technique [0002] Staphylococcal Enterotoxin is produced by Staphylococcus aureus. More than 20 types of enterotoxins have been identified, including classic enterotoxins such as SEA, SEB, SEC, SED, SEE, etc., and newly discovered enterotoxins SEG-SEQ. The molecular weight of different types of enterotoxins ranges from 25 to 33 kD, and the amino acid sequences of various types of enterotoxins have certain homology (28% to 98%). A...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/085C12N15/31C12N15/70C07K14/31A61P35/00A61P37/04
Inventor 陈枢青丁丁
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products